Chaos Theory: Understanding the Genetic Chaos of Soft Tissue Sarcoma
The 50 cancers under the umbrella of soft tissue sarcoma are marked by genetic chaos, and a growing understanding of these mutations may lead to new treatments.
Read More
Melanoma: Fertile Territory for the Development of New Treatments
In clinical trials, melanoma remains a ripe discovery ground for the application and combination of immunotherapies and targeted drugs.
The Next Frontier: The Promise of Immunotherapy in Gastrointestinal Cancers
In the oncology world, gastrointestinal cancers may be the next in line to realize the promise of immunotherapy.
Brain Trust: Cutting-Edge Treatments for Glioblastoma on the Rise
New treatments, such as immunotherapy, are continuing to prove successful for patients with glioblastoma, one of the most dangerous cancers.
Hitting a Target in Advanced Non-Small Cell Lung Cancer
Targeted drugs, as well as immunotherapies, are beginning to change the treatment outlook for people with advanced non-small cell lung cancer.
Angelina Jolie Sparks Rise in Genetic Testing for Treat Breast Cancer
Angelina Jolie has highlighted the benefits of genetic testing and surgery to prevent hereditary breast cancer, but women must also consider the risks.
CAR Pool: Immunotherapies Improving Outcomes in ALL
For adults with acute leukemia, CAR T cell immunotherapies, targeted drugs and pediatric chemotherapy regimens are improving outcomes.
Setting Off a Smart Bomb
By empowering the body to fight breast and renal cancers, immunotherapies are poised to improve the treatment landscape.
